Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.5900 (-1.37%) ($3.5900 - $3.5900) on Tue. Jan. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.46% (three month average) | RSI | 17 | Latest Price | $3.5900(-1.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -6.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(85%) ARKK(82%) ARKG(81%) IBUY(81%) IWO(81%) | Factors Impacting CGEN price | CGEN will decline at least -2.23% in a week (0% probabilities). VIXM(-72%) VXX(-53%) UUP(-27%) UNG(-14%) EDOC(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.23% (StdDev 4.46%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.28(-358.5%) | Resistance Level | $4.03 | 5 Day Moving Average | $3.7(-2.97%) | 10 Day Moving Average | $3.81(-5.77%) | 20 Day Moving Average | $4.03(-10.92%) | To recent high | -49.9% | To recent low | 0% | Market Cap | $297m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |